The Gildersleeve laboratory at the National Cancer Institute has an opening for a postdoctoral fellow starting on or after October 1, 2021. The goal of our research program is to develop and investigate carbohydrate-binding antibodies for cancer applications.  We use glycan microarray technology as well as chemical, biochemical, and molecular biology approaches to design and develop new carbohydrate-binding antibodies as research tools, diagnostics, and therapeutics.  This project will involve developing new strategies for design and discovery of anti-carbohydrate antibodies for cancer applications. Candidates with experience in antibody development and discovery, protein engineering, glycobiology, and/or directed evolution are especially encouraged to apply.

 

Additional information about our research can be found at:  https://ccr.cancer.gov/Chemical-Biology-Laboratory/jeffrey-c-gildersleeve.  The Gildersleeve Lab is part of the Chemical Biology Laboratory (CBL) of the NCI in Frederick, MD.  More information about the CBL can be found at:  http://ccr2.cancer.gov/resources/cbl/

 

Ph.D. in Chemical Biology, Biochemistry, or related field

Less than 1 year of prior postdoctoral experience

 

Interested applicants should send their CV, a brief description of their research experience, and contact information for three references to Dr. Jeff Gildersleeve by email to [email protected].  Please also include an estimate of when you would be available to start.